Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12.50 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orexo US, Inc. | $12.50 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $12.50 | 1 | Orexo US, Inc. ($12.50) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2020 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Addiction Medicine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 86 | 286 | $46,800 | $26,016 |
| 2022 | 3 | 65 | 312 | $60,600 | $32,664 |
| 2021 | 3 | 100 | 315 | $60,300 | $33,216 |
| 2020 | 4 | 115 | 402 | $72,800 | $37,483 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 88 | $17,600 | $9,396 | 53.4% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 22 | 82 | $16,400 | $9,195 | 56.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 28 | 92 | $9,200 | $5,603 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 24 | $3,600 | $1,822 | 50.6% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 20 | 99 | $29,700 | $15,289 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 96 | $19,200 | $10,207 | 53.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 23 | 117 | $11,700 | $7,168 | 61.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 27 | 91 | $27,300 | $14,250 | 52.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 106 | $21,200 | $11,634 | 54.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 38 | 118 | $11,800 | $7,333 | 62.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 24 | 71 | $21,300 | $11,021 | 51.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 121 | $24,200 | $10,421 | 43.1% |
| 80307 | Testing for presence of drug | Office | 2020 | 36 | 147 | $14,700 | $8,999 | 61.2% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 20 | 63 | $12,600 | $7,042 | 55.9% |
About Dr. Igor Stavitsky, M.D
Dr. Igor Stavitsky, M.D is a Emergency Medicine healthcare provider based in Lawrence, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023094471.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Igor Stavitsky, M.D has received a total of $12.50 in payments from pharmaceutical and medical device companies, with $12.50 received in 2020. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($12.50).
As a Medicare-enrolled provider, Stavitsky has provided services to 366 Medicare beneficiaries, totaling 1,315 services with total Medicare billing of $129,380. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Lawrence, MA
- Active Since 12/19/2005
- Last Updated 07/18/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023094471
Products in Payments
- Zubsolv (Drug) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Lawrence
Dr. Kye Evans, D.o, D.O
Emergency Medicine — Payments: $2,141
Adam Mandel, D.o, D.O
Emergency Medicine — Payments: $1,528
Jorge Botero, M.d, M.D
Emergency Medicine — Payments: $776.93
Dr. Khylie Wurdeman, Md, MD
Emergency Medicine — Payments: $530.33
Dr. Caleb Trent, Md, MD
Emergency Medicine — Payments: $270.04
Dr. John Lucas, M.d, M.D
Emergency Medicine — Payments: $236.39